# A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

> **NCT00441896** · PHASE2 · COMPLETED · sponsor: **Marinus Pharmaceuticals** · enrollment: 57 (actual)

## Conditions studied

- Infantile Spasms

## Interventions

- **DRUG:** Ganaxolone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00441896
- **Lead sponsor:** Marinus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441896, "A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00441896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*